Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Tamer EL Nahas"'
Autor:
Neemat M. Kassem, Hamdy EL Zawam, Heba A. Kassem, Tamer EL Nahas, Noha M. El Husseiny, Hamdy Abd El Azeeim
Publikováno v:
Journal of the Egyptian National Cancer Institute, Vol 26, Iss 2, Pp 67-71 (2014)
Background: Plasma cell dyscrasias (PCDs) refer to a spectrum of disorders characterized by the monoclonal proliferation of lymphoplasmacytic cells in the bone marrow and, sometimes, tissue deposition of monoclonal immunoglobulins or their components
Externí odkaz:
https://doaj.org/article/d738ee3480af4b02b2ff914a7ee579f0
Publikováno v:
Research in Oncology. :1-7
Autor:
Tamer El-Nahas, Cynthia Villarreal-Garza, Sandra Ximena Franco, Sergio Daniel Simon, Florencia Perazzo, Maria Konstantinova, Shaheenah Dawood, Sung-Bae Kim
Publikováno v:
Chinese Clinical Oncology. 9:61-61
The therapeutic landscape of human epidermal growth factor receptor 2-negative (HER2-) metastatic breast cancer (mBC) has evolved considerably with the introduction of newer targeted agents such as poly-ADP ribose polymerase inhibitors (PARPi), novel
Autor:
Noha M. El Husseiny, Hamdy El Zawam, Hamdy Abd El Azeeim, Neemat M Kassem, Heba A. Kassem, Tamer El Nahas
Publikováno v:
Journal of the Egyptian National Cancer Institute, Vol 26, Iss 2, Pp 67-71 (2014)
Background Plasma cell dyscrasias (PCDs) refer to a spectrum of disorders characterized by the monoclonal proliferation of lymphoplasmacytic cells in the bone marrow and, sometimes, tissue deposition of monoclonal immunoglobulins or their components.
Publikováno v:
Research in Oncology. 10:6-11
Background: Colorectal cancer (CRC) is usually a disease of older patients. Despite this fact, we noticed ahigher ercentage of patients presented at younger age group (between 20 – 40 years). So we planned this study to document the real incidence
Publikováno v:
Research in Oncology. 9:69-73
Publikováno v:
IOSR Journal of Dental and Medical Sciences. 11:65-71
Aim of the work: The objectives of this study were to evaluate the efficacy and toxicity of combination chemotherapy with cisplatin and gemcitabine in patients with inoperable or metastatic pancreatic cancer. Patients and Methods: the study included
Publikováno v:
Research in Oncology. 6:39-46
Publikováno v:
Research in Oncology. 5:25-29
Role of FISH Analysis in The Prediction of Treatatment Outcome in Adult Patiatients with de novo AML
Autor:
Mazen Elsharkawy, Yasser Abdelkader, Amina Abdelwahed, Hamdy Zawam, Tamer El-Nahas, Yasser Hassan
Publikováno v:
Research in Oncology. 2:71-74
Patients and Methods: During the years 2001-2004, a total number of 28 patients with de novo AML were analyzed by FISH to compare the prognostic impact of certain hematological, clinical parameters and cytogenetic abnormalities on CR rates, disease f